Christopher van Dyck MD

Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit

Clinical Interests

Alzheimer's Disease; Cognitive Aging; Neuroimaging


Board Certifications

1991
Psychiatry, Board Certified

Patient Care Locations

christopher_vandyckfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Alzheimer's DiseaseAmyloid imaging in subjects with and at risk for Alzheimer’s disease:- a positron emission tomography (PET) study
Alzheimer´s DiseaseA Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease
Alzheimer´s DiseaseRandomized, Double-Blind, Placebo-Controlled, Parallell-Group, 12-Month Trial of Leuco-methythionium bis(hydromethanesulfonate) in Subjects With Mild to Moderate Alzheimer's Disease
Alzheimer´s DiseaseBAN2401-G000-201: A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Alzheimer's DiseaseEffect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo (Study H8A-MC-LZAX)

More Clinical Trials...

Edit Profile